Page of

Non-small cell lung cancer and superior vena cava obstruction: Non-small cell lung cancer and superior vena cava obstruction Expert commentary Clive Mulatero Expert commentary Clive Mulatero 

Non-small cell lung cancer and superior vena cava obstruction: Non-small cell lung cancer and superior vena cava obstruction Expert commentary Clive Mulatero Expert commentary Clive Mulatero
Chapter:
Non-small cell lung cancer and superior vena cava obstruction: Expert commentary Clive Mulatero
Source:
Challenging Concepts in Oncology
Author(s):

Laura Beaton

, and Swee-Ling Wong

DOI:
10.1093/med/9780199688883.003.0002

Non-small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancers. Patients frequently present with a variety of non-specific symptoms including cough and dyspnoea and more rarely with symptoms such as haemoptysis or the signs of superior vena cava obstruction (SVCO), as illustrated in this case. Treatment strategies in early and recurrent disease are discussed including the role of tyrosine kinase inhibitors against tumours with epidermal growth factor receptor (EGFR) sensitising mutations.

Sign In

Copyright © 2020. All rights reserved.